ARTICLE | Company News
Amgen sales and marketing update
September 20, 2010 7:00 AM UTC
Amgen launched Prolia denosumab in Canada and Switzerland to treat postmenopausal women with osteoporosis at high risk for fracture. The wholesale acquisition cost (WAC) of a 60 mg/mL injection of th...